Page last updated: 2024-08-24

3-n-butylphthalide and Allergic Encephalomyelitis

3-n-butylphthalide has been researched along with Allergic Encephalomyelitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bi, Y; Chen, L; Guo, L; Li, B; Shi, W; Wang, Y; Xia, Z	1

Other Studies

1 other study(ies) available for 3-n-butylphthalide and Allergic Encephalomyelitis

Article	Year
Butylphthalide ameliorates experimental autoimmune encephalomyelitis by suppressing PGAM5-induced necroptosis and inflammation in microglia. Biochemical and biophysical research communications, 2018, 02-26, Volume: 497, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Apoptosis Regulatory Proteins; Benzofurans; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Male; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Necrosis; Neuroprotective Agents; Phosphoprotein Phosphatases; Treatment Outcome	2018

Article

Year

Butylphthalide ameliorates experimental autoimmune encephalomyelitis by suppressing PGAM5-induced necroptosis and inflammation in microglia.

Biochemical and biophysical research communications, 2018, 02-26, Volume: 497, Issue:1

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Apoptosis Regulatory Proteins; Benzofurans; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Male; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Necrosis; Neuroprotective Agents; Phosphoprotein Phosphatases; Treatment Outcome

2018